Related Experiment Video
Updated: Aug 13, 2025
Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
Published on: February 22, 2015
Identification of Therapeutic Targets for Medulloblastoma by Tissue-Specific Genome-Scale Metabolic Model
Ilkay Irem Ozbek1, Kutlu O Ulgen1
1Chemical Engineering Department, Bogazici University, Bebek, Istanbul 34342, Turkey.
Abstract:
Medulloblastoma (MB), occurring in the cerebellum, is the most common childhood brain tumor. Because conventional methods decline life quality and endanger children with detrimental side effects, computer models are needed to imitate the characteristics of cancer cells and uncover effective therapeutic targets with minimum toxic effects on healthy cells. In this study, metabolic changes specific to MB were captured by the genome-scale metabolic brain model integrated with transcriptome data. To determine the roles of sphingolipid metabolism in proliferation and metastasis in the cancer cell, 79 reactions were incorporated into the MB model. The pathways employed by MB without a carbon source and the link between metastasis and the Warburg effect were examined in detail. To reveal therapeutic targets for MB, biomass-coupled reactions, the essential genes/gene products, and the antimetabolites, which might deplete the use of metabolites in cells by triggering competitive inhibition, were determined. As a result, interfering with the enzymes associated with fatty acid synthesis (FAs) and the mevalonate pathway in cholesterol synthesis, suppressing cardiolipin production, and tumor-supporting sphingolipid metabolites might be effective therapeutic approaches for MB. Moreover, decreasing the activity of succinate synthesis and GABA-catalyzing enzymes concurrently might be a promising strategy for metastatic MB.
Insights
Computer models reveal new therapeutic targets for medulloblastoma (MB), the most common childhood brain tumor. Strategies include targeting fatty acid synthesis, cholesterol pathways, and specific metabolic enzymes to minimize side effects.
Area of Science:
- Computational Biology
- Cancer Metabolism
- Genomics
Background:
- Medulloblastoma (MB) is the most common pediatric brain tumor, often treated with therapies causing significant side effects.
- Conventional treatments for MB can reduce quality of life and pose risks to children.
- Developing novel therapeutic targets with minimal toxicity is crucial for MB treatment.
Purpose of the Study:
- To create a genome-scale metabolic model of MB by integrating transcriptome data.
- To investigate the role of sphingolipid metabolism in MB proliferation and metastasis.
- To identify potential therapeutic targets and antimetabolites for MB treatment.
Main Methods:
- Construction of a genome-scale metabolic brain model for MB.
- Integration of transcriptome data to capture MB-specific metabolic changes.
- Incorporation of 79 reactions to analyze sphingolipid metabolism, carbon source utilization, and the Warburg effect in MB.
Main Results:
- Identification of essential genes and biomass-coupled reactions for MB.
- Determination of antimetabolites for potential therapeutic intervention.
- Key findings suggest targeting fatty acid synthesis, cholesterol synthesis (mevalonate pathway), cardiolipin production, and sphingolipid metabolism.
Conclusions:
- Interfering with enzymes in fatty acid and cholesterol synthesis pathways shows therapeutic potential for MB.
- Suppressing cardiolipin production and targeting tumor-promoting sphingolipids are promising strategies.
- Concurrent reduction of succinate synthesis and GABA-catalyzing enzymes may be effective for metastatic MB.
More Related Videos
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
09:24Generation of Microtumors Using 3D Human Biogel Culture System and Patient-derived Glioblastoma Cells for Kinomic Profiling and Drug Response Testing
Published on: June 9, 2016